Log in
NASDAQ:TRHC

Tabula Rasa HealthCare Stock Forecast, Price & News

$39.45
+0.20 (+0.51 %)
(As of 10/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$38.57
Now: $39.45
$39.69
50-Day Range
$38.50
MA: $42.35
$50.08
52-Week Range
$33.04
Now: $39.45
$69.72
Volume204,167 shs
Average Volume246,969 shs
Market Capitalization$905.77 million
P/E RatioN/A
Dividend YieldN/A
Beta1.08
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the field of medication safety in the United States. The company's proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. Its cloud-based software applications include EireneRx, a medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems. The company's cloud-based software also comprise RxCompanion, an MTM software platform designed to aid in the identification and resolution of medication and other health related problems.; TruChart, an electronic health record (EHR) system for Programs of All-Inclusive Care for the Elderly (PACE) programs; and PACElogic, which deliver real-time sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination, planning, integration with community-based providers, and various Federal and State required reporting. Tabula Rasa HealthCare, Inc. also offers clinical pharmacist collaboration, prescription fulfillment and reminder packaging, and pharmacy cost management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2019, it served 237 healthcare organizations. The company offers its cloud-based software solutions to prescribers, pharmacists, pharmacies, and healthcare organizations for managing the medication-related needs of patients. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.
Read More
Tabula Rasa HealthCare logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.54 out of 5 stars

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TRHC
CUSIPN/A
Phone866-648-2767
Employees1,286

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$284.71 million
Cash Flow$1.82 per share
Book Value$8.36 per share

Profitability

Net Income$-32,440,000.00

Miscellaneous

Market Cap$905.77 million
Next Earnings Date11/3/2020 (Confirmed)
OptionableOptionable
$39.45
+0.20 (+0.51 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TRHC News and Ratings via Email

Sign-up to receive the latest news and ratings for TRHC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Tabula Rasa HealthCare (NASDAQ:TRHC) Frequently Asked Questions

How has Tabula Rasa HealthCare's stock price been impacted by Coronavirus?

Tabula Rasa HealthCare's stock was trading at $45.88 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, TRHC shares have decreased by 14.0% and is now trading at $39.45.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Tabula Rasa HealthCare?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 1 hold rating and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Tabula Rasa HealthCare
.

When is Tabula Rasa HealthCare's next earnings date?

Tabula Rasa HealthCare is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Tabula Rasa HealthCare
.

How can I listen to Tabula Rasa HealthCare's earnings call?

Tabula Rasa HealthCare will be holding an earnings conference call on Tuesday, November 3rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) released its quarterly earnings data on Tuesday, August, 4th. The company reported $0.07 EPS for the quarter, topping analysts' consensus estimates of ($0.22) by $0.29. The firm earned $76.80 million during the quarter, compared to the consensus estimate of $78.12 million. Tabula Rasa HealthCare had a negative return on equity of 7.37% and a negative net margin of 14.70%. The business's revenue for the quarter was up .7% on a year-over-year basis. During the same quarter last year, the company earned $0.35 earnings per share.
View Tabula Rasa HealthCare's earnings history
.

What guidance has Tabula Rasa HealthCare issued on next quarter's earnings?

Tabula Rasa HealthCare issued an update on its third quarter 2020 After-Hours earnings guidance on Tuesday, August, 4th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $74-78 million, compared to the consensus revenue estimate of $87.78 million.

What price target have analysts set for TRHC?

10 brokerages have issued 12-month price objectives for Tabula Rasa HealthCare's stock. Their forecasts range from $46.00 to $83.00. On average, they anticipate Tabula Rasa HealthCare's stock price to reach $65.30 in the next twelve months. This suggests a possible upside of 65.5% from the stock's current price.
View analysts' price targets for Tabula Rasa HealthCare
.

Who are some of Tabula Rasa HealthCare's key competitors?

What other stocks do shareholders of Tabula Rasa HealthCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), QUALCOMM (QCOM), Adobe (ADBE), Micron Technology (MU), Canopy Growth (CGC), The Boeing (BA), salesforce.com (CRM), Intel (INTC) and Netflix (NFLX).

Who are Tabula Rasa HealthCare's key executives?

Tabula Rasa HealthCare's management team includes the following people:
  • Dr. Calvin H. Knowlton, Co-Founder, Chairman & CEO (Age 70, Pay $616.28k)
  • Dr. Orsula Voltis Knowlton M.B.A., Pharm.D., BScPharm, PharmD, MBA, Co-Founder, Pres, Chief Marketing & New Bus. Devel. Officer and Director (Age 51, Pay $470.08k)
  • Mr. Brian W. Adams, CFO & Sec. (Age 38, Pay $647.74k)
  • Mr. Michael Greenhalgh, Chief Operating Officer (Age 58)
  • Ms. Andrea Carolan Speers, Corp. Controller & Chief Accounting Officer (Age 38)

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray served as the underwriters for the IPO and Baird and Stifel were co-managers.

What is Tabula Rasa HealthCare's stock symbol?

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

Who are Tabula Rasa HealthCare's major shareholders?

Tabula Rasa HealthCare's stock is owned by a number of retail and institutional investors. Top institutional investors include Peregrine Capital Management LLC (0.94%), Summit Creek Advisors LLC (0.89%), Taylor Wealth Management Partners (0.45%), Envestnet Asset Management Inc. (0.08%), Louisiana State Employees Retirement System (0.04%) and Exane Derivatives (0.01%). Company insiders that own Tabula Rasa HealthCare stock include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Michael Greenhalgh, Orsula V Knowlton and Samira Beckwith.
View institutional ownership trends for Tabula Rasa HealthCare
.

Which major investors are selling Tabula Rasa HealthCare stock?

TRHC stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, and Summit Creek Advisors LLC. Company insiders that have sold Tabula Rasa HealthCare company stock in the last year include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Michael Greenhalgh, Orsula V Knowlton, and Samira Beckwith.
View insider buying and selling activity for Tabula Rasa HealthCare
.

Which major investors are buying Tabula Rasa HealthCare stock?

TRHC stock was purchased by a variety of institutional investors in the last quarter, including Louisiana State Employees Retirement System, Exane Derivatives, Exane Derivatives, Taylor Wealth Management Partners, Harbor Investment Advisory LLC, and Envestnet Asset Management Inc..
View insider buying and selling activity for Tabula Rasa HealthCare
.

How do I buy shares of Tabula Rasa HealthCare?

Shares of TRHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Tabula Rasa HealthCare's stock price today?

One share of TRHC stock can currently be purchased for approximately $39.45.

How big of a company is Tabula Rasa HealthCare?

Tabula Rasa HealthCare has a market capitalization of $905.77 million and generates $284.71 million in revenue each year. The company earns $-32,440,000.00 in net income (profit) each year or ($0.25) on an earnings per share basis. Tabula Rasa HealthCare employs 1,286 workers across the globe.

What is Tabula Rasa HealthCare's official website?

The official website for Tabula Rasa HealthCare is www.tabularasahealthcare.com.

How can I contact Tabula Rasa HealthCare?

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The company can be reached via phone at 866-648-2767 or via email at [email protected]

This page was last updated on 10/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.